Studies indicate CBD Clinic™ hemp topicals for
massage do not irritate, or penetrate into the bloodstream, after
high-frequency, repeated use such as in massage therapy
DENVER, May 25, 2022
/CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," "CW" or the "Company"), the
market leader in full-spectrum hemp extract CBD products, today
announced results from a series of clinical research studies on
frequent use of Charlotte's Web
CBD Clinic™ branded topicals in regular and hot stone
massage.
The studies included:
- Clinical Safety Testing (CBD Clinic™ Relax Massage Cream) –
Repeated Insult Patch test
- Clinical Safety Testing (CBD Clinic™ Relax Massage Cream) – A
five-week 60 subject clinical study
The research found that high-frequency repeated use, typical
with massage therapists, of Charlotte's Web CBD Clinic™ massage products
did not lead to systemic absorption of cannabinoid metabolites in
the bloodstream, nor did the products cause skin irritation.
An expert opinion paper was prepared based on the studies'
findings ["Expert Opinion on the Safety Profile of CW Full-Spectrum
Hemp Extract in the Practice of Massage Therapy"]. The opinion
paper was conducted by third-party clinical research organizations,
Charlottes Web's CW Labs division, and a comprehensive literature
review. The paper was prepared by Dr. Sherry Bradford, Ph.D. Biochemistry. Dr.
Bradford is a former faculty member of University at Buffalo and an editorial board member
of The Scientific Federation of Oncology and Cancer (Editor in
Chief) and the Journal of Biomolecular Research and Therapy. In the
opinion paper, Dr. Bradford found: "The scientific data and
research performed on the safety and skin permeation of
Charlotte's Web CBD Clinic™ hemp
topical products support safe repeated use by MTs [massage
therapists], for massage clients, and in normal (heat generated
from friction only) and hot stone (additional heat applied)
massages."
Charlotte's Web, a certified B
Corporation, is committed to building a responsible, science-driven
and transparent industry for those seeking access to safe,
high-quality hemp wellness products. These clinical studies are
among many formal scientific investigations supported by the
Company's CW Labs division.
"These research findings and expert opinion add to the growing
body of evidence-based research for Charlotte's Web CBD Clinic topical products,"
said Tim Orr, President of
Charlotte's Web R&D division,
CW Labs. "Massage therapists can be confident they're working
with some of the safest, highest-quality hemp CBD products when
they choose CBD Clinic by Charlotte's Web."
About CBD Clinic™
Topicals
CBD Clinic™ topicals help target varying levels of discomfort
through high-quality, naturally derived active ingredients menthol
and camphor. These cooling & heating counterirritants distract
the brain's pain signals for the temporary relief of minor aches of
muscles and joints. In addition, they are made with moisturizing
and essential oils such as clove oil, eucalyptus oil, jojoba oil,
and hemp extract (varies by product). Perfect for sore tendons and
tissues that need a little extra care.
About CW Labs
Charlotte's Web Labs ("CW
Labs") is the research and development division of Charlotte's Web, advancing science around
hemp-derived phytocannabinoids, terpenes and flavonoid compounds.
CW Labs is comprised of two centers of excellence: The
Company's R&D facility located in Louisville, Colorado with expertise in liquid
and gas chromatography, mass spectroscopy and organic chemistry,
and our formulation chemistry and clinical research R&D center
located at the Hauptmann Woodward Research Institute on the campus
of the University at Buffalo's Jacobs
School of Medicine and The Center for Integrated Global Biomedical
Sciences, and is part of the State University
of New York (SUNY) network.
Research funding and product support are provided by the CW Labs
division of Charlotte's Web
Inc.
About Charlotte's Web Holdings, Inc.
Charlotte's Web Holdings, Inc.,
a Certified B Corporation headquartered in Denver, is the market leader in innovative
hemp extract wellness products under a family of brands which
includes Charlotte's Web™, CBD
Medic™, CBD Clinic™, and Harmony Hemp™. Charlotte's Web branded premium quality
products start with proprietary hemp genetics that are 100-percent
American farm-grown using organic and regenerative cultivation
practices. The Company's hemp extracts have naturally
occurring botanical compounds including cannabidiol ("CBD"), CBC,
CBG, terpenes, flavonoids, and other beneficial
compounds. The Company's CW Labs R&D division advances
hemp science at two centers of excellence in Louisville, Colorado, and the Hauptmann
Woodward Research Institute at the University
at Buffalo, part of the State
University of New York (SUNY)
network. Web product categories include full-spectrum hemp CBD oil
tinctures (liquid products), CBD gummies (sleep, stress,
exercise recovery), CBD capsules, CBD topical creams and lotions,
as well as CBD pet products for dogs. Through its vertically
integrated business model, Charlotte's Web maintains stringent control
over product quality and consistency with 20+ product lot testing
for quality assurance. Charlotte's
Web products are distributed to more than 15,000 retail, over 8,000
health care practitioners, and online through the Company's website
at www.CharlottesWeb.com. Charlotte's Web's mission is
"To unleash the healing powers of botanicals with compassion and
science, benefitting the planet and all who live upon it."
Forward-Looking
Information
Certain information in this news release constitutes
forward-looking statements and forward-looking information within
the meaning of applicable securities laws (collectively,
"forward-looking information"). In some cases, but not
necessarily in all cases, forward looking information can be
identified by the use of forward-looking terminology such as
"plans", "targets", "expects" or "does not expect", "is expected",
"an opportunity exists", "is positioned", "estimates", "intends",
"assumes", "anticipates" or "does not anticipate" or "believes", or
variations of such words and phrases or state that certain
actions, events or results "may", "could", "would", "might", "will"
or "will be taken", "occur" or "be achieved". In addition, any
statements that refer to expectations, projections or other
characterizations of future events or circumstances contain
forward-looking information. Specifically, this news release
contains forward-looking information relating to, among others: the
future of Charlotte's Web and the
impacts of management changes.
Statements containing forward-looking information are not
historical facts but instead represent management's current
expectations, estimates and projections regarding the future of
our business, future plans, strategies, projections, anticipated
events and trends, the economy and other future conditions.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by the Company as of the date of this news release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information. The
material factors and assumptions used to develop the
forward-looking information herein include, but are not limited to,
the following: the impact of the COVID-19 pandemic; the regulatory
climate in which the Company currently operates and may in the
future operate; consumer interest in CBD; successful sales of the
Company's products; and the success of sales and marketing
activities. Important factors that could cause actual results and
financial condition to differ materially from those indicated in
the forward-looking information include, among others, the factors
discussed throughout the "Risk Factors" section of the Company's
most recently filed Annual Report on Form 10-K for the year ended
December 31, 2021 available on
www.SEDAR.com and www.sec.gov , and other risk factors contained in
other filings with the Securities and Exchange Commission available
on www.sec.gov and filings with Canadian securities regulatory
authorities available on www.sedar.com. Except as
required by applicable securities laws, the Company undertakes no
obligation to publicly update any forward-looking information,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clinical-studies-support-charlottes-web-cbd-clinic-topicals-as-safe-for-massage-and-frequent-use-301554924.html
SOURCE Charlotte's Web
Holdings, Inc.